Ivermectin Export Market Intelligence: India's 352 Suppliers Shipping to 140 Countries — TransData Nexus 2026

Q: Who are the top ivermectin exporters from India?

The top ivermectin exporters from India are: 1. SAVA HEALTHCARE LIMITED — $2.3M (27.0% market share); 2. ZYDUS LIFESCIENCES LIMITED — $596.5K (6.9% market share); 3. ANTILA LIFESCIENCES PRIVATE LIMITED — $511.4K (5.9% market share); 4. RUBICON RESEARCH LIMITED — $453.2K (5.2% market share); 5. BULL PHARMACHEM — $412.0K (4.7% market share). Together they account for 49.7% of India's total ivermectin export value.

Q: What is the total export value of ivermectin from India?

The total export value of ivermectin from India is $8.7M USD, recorded across 11,765 shipment transactions from 352 active exporters to 140 destination countries. The average shipment value is $738.

Q: Which countries import ivermectin from India?

India exports ivermectin to 140 countries worldwide. The top importing countries are: MAURITIUS (30.5% share, $2.6M), UNITED STATES (15.4% share, $1.3M), MADAGASCAR (10.4% share, $905.8K), UNITED ARAB EMIRATES (7.9% share, $688.3K), AFGHANISTAN (3.9% share, $340.7K). These five markets account for 68.2% of total export value.

Q: What is the HS code for ivermectin exports from India?

The primary HS code for ivermectin exports from India is 30049099. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) for tracking and reporting pharmaceutical trade flows.

Q: What is the average price of ivermectin exports from India?

The average unit price for ivermectin exports from India is $2.31 USD per unit, with prices ranging from $0.00 to $1080.56 depending on formulation, packaging, and order volume. The total market is valued at $8.7M across 11,765 shipments.

Q: Which ports handle ivermectin exports from India?

The primary ports for ivermectin exports from India are SAHAR AIR CARGO ACC (INBOM4) (35.7% of shipments), SAHAR AIR (22.5% of shipments), DELHI AIR CARGO ACC (INDEL4) (13.1% of shipments), DELHI AIR (6.9% of shipments), Bombay Air (6.9% of shipments). These ports have dedicated pharmaceutical cargo infrastructure ensuring cold-chain and regulatory compliance during transit.

Q: Why is India a leading exporter of ivermectin?

India is one of the world's leading exporters of ivermectin due to its large base of 352 WHO-GMP and US FDA approved manufacturers, significantly lower production costs compared to Western markets, well-established API (Active Pharmaceutical Ingredient) supply chains, and strong government support for pharmaceutical exports through the Pharmaceuticals Export Promotion Council (Pharmexcil). India exports ivermectin to 140 countries, demonstrating 72% global market coverage.

Q: What certifications do Indian ivermectin exporters need?

Indian ivermectin exporters typically require WHO-GMP (Good Manufacturing Practice) certification for most regulated markets, US FDA approval for exports to the United States, EU GMP certification for European markets, and country-specific regulatory approvals for markets in Africa, Asia, and Latin America. Additional certifications may include ISO 9001, Schedule M compliance under Indian drug laws, and Free Sale Certificates issued by the Central Drugs Standard Control Organization (CDSCO).

Q: How many buyers import ivermectin from India?

There are 712 registered buyers importing ivermectin from India, spread across 140 countries. The repeat buyer rate is 48.3%, indicating strong long-term trade relationships and consistent product quality.

Q: What is the market share of the top ivermectin supplier from India?

SAVA HEALTHCARE LIMITED is the leading ivermectin exporter from India with a market share of 27.0% and total export value of $2.3M across 346 shipments. The top 5 suppliers together control 49.7% of total export value.

Suresh Sormare

Ivermectin

India Pharmaceutical Trade Intelligence

$8.7M352 Suppliers140 CountriesHS 30049099

ExportsIndia → MAURITIUS30.5%India → UNITED STATES15.4%

ImportsCHINA → India$324.4M SPAIN → India$258.9K

#1 Supplier: SAVA HEALTHCARE #1 Buyer: REGENCY PHARMA

Ivermectin Export Analysis | India Pharmaceutical Trade Intelligence | TransData Nexus

How India Exports Ivermectin to the World

Between 2022 and 2026, India exported $8.7M worth of ivermectin across 11,765 verified shipments to 140 countries — covering 72% of world markets in the Antimalarial & Antiparasitic segment. The largest destination is MAURITIUS (30.5%). SAVA HEALTHCARE LIMITED leads with a 27.0% share. All figures are drawn from Indian Customs (DGFT) shipping bill records spanning four years of trade activity.

Source: Indian Customs (DGFT)·Published March 2026·Updated March 2026·

Ivermectin export data from India — top exporters, importing countries, pricing and trade statistics compiled by TransData Nexus — Ivermectin export data snapshot — $8.7M · 352 exporters · 140 countriesTransData Nexus · Indian Customs Data

Top Ivermectin Exporters from India

352 active exporters · Ranked by export value

View all 352 →

Top Ivermectin Exporters from India — Ranked by Export Value
#	Supplier Name	Export Value (USD)	Shipments	Countries	Market Share
1	SAVA HEALTHCARE LIMITED	$2.3M	346	2	27.0%
2	ZYDUS LIFESCIENCES LIMITED

Top Countries Importing Ivermectin from India

140 destination markets · Ranked by import value

All 140 countries →

Top Countries Importing Ivermectin from India — Ranked by Import Value
#	Country	Import Value (USD)	Market Share
1	MAURITIUS	$2.6M	30.5%
2	UNITED STATES	$1.3M	15.4%
3	MADAGASCAR	$905.8K	10.4%
4	UNITED ARAB EMIRATES	$688.3K	7.9%
5	AFGHANISTAN	$340.7K	3.9%
6	NIGERIA	$272.6K	3.1%
7	KENYA	$240.4K	2.8%
8	TURKMENISTAN	$221.5K	2.6%
9	CAMBODIA	$197.1K	2.3%
10	SINGAPORE	$184.1K	2.1%

MAURITIUS is India's largest ivermectin export destination, absorbing 30.5% of total exports worth $2.6M. The top 5 importing countries — MAURITIUS, UNITED STATES, MADAGASCAR, UNITED ARAB EMIRATES, AFGHANISTAN — together account for 68.2% of India's total ivermectin export value. The remaining 135 destination countries collectively receive the other 31.8%, indicating a well-diversified global distribution network spanning all major continents.

Who Supplies Ivermectin to India?

11 origin countries · Total import value: $324.8M

India imports ivermectin from 11 countries with a combined import value of $324.8M. The largest supplier is CHINA ($324.4M, 6 shipments), followed by SPAIN and UNITED STATES. All values are from Indian Customs (DGFT) import records.

Countries Supplying Ivermectin to India — Ranked by Import Value
#	Origin Country	Import Value (USD)	Shipments	Share
1	CHINA	$324.4M	6	99.9%
2	SPAIN	$258.9K	7	0.1%
3	UNITED STATES	$86.3K	47	0.0%
4	CANADA	$23.5K	6	0.0%
5	UNITED ARAB EMIRATES	$19.4K	2	0.0%
6	BRAZIL	$6.4K	2	0.0%
7	ISRAEL	$5.0K	2	0.0%
8	FRANCE	$4.1K	6	0.0%
9	UNITED KINGDOM	$2.1K	2	0.0%
10	TURKEY	$560	5	0.0%

Showing top 10 of 11 origin countries

CHINA is the largest supplier of ivermectin to India, accounting for 99.9% of total import value. The top 5 origin countries — CHINA, SPAIN, UNITED STATES, CANADA, UNITED ARAB EMIRATES — together supply 100.0% of India's ivermectin imports. Click any country to see detailed supplier and buyer data for that import corridor.

Regulatory Landscape — Ivermectin

Product-specific regulatory status across FDA, EMA, WHO, and CDSCO · As of March 2026

1FDA & US Market Regulatory Status

In the United States, ivermectin is approved for human use primarily for the treatment of parasitic infections. The FDA's Orange Book lists multiple approved Abbreviated New Drug Applications (ANDAs) for ivermectin, indicating a competitive generic market. As of March 2026, there are no active FDA import alerts specifically targeting ivermectin products from India, suggesting compliance with U.S. regulatory standards. However, the FDA maintains vigilance through import alerts to ensure that imported drugs meet safety and efficacy standards. Given that 15.4% of India's ivermectin exports are destined for the U.S., it is imperative for Indian exporters to adhere strictly to FDA regulations to maintain market access.

2EU & UK Regulatory Framework

In the European Union and the United Kingdom, ivermectin is authorized for both human and veterinary use. The European Medicines Agency (EMA) has evaluated ivermectin-containing products, particularly for veterinary applications, to ensure their safety and efficacy. For instance, in December 2007, the EMA reviewed injectable veterinary products containing ivermectin for cattle, addressing concerns about varying withdrawal periods across member states. (ema.europa.eu) Manufacturers exporting to the EU and UK must comply with Good Manufacturing Practice (GMP) requirements and obtain appropriate marketing authorizations from the EMA or the UK's Medicines and Healthcare products Regulatory Agency (MHRA).

3WHO Essential Medicines & Global Standards

Ivermectin is included in the World Health Organization's (WHO) Model List of Essential Medicines, underscoring its importance in treating parasitic infections. The 24th edition of the list, updated in September 2025, continues to feature ivermectin. (who.int) This inclusion reflects its critical role in global health. Additionally, ivermectin is recognized in various pharmacopoeias, including the United States Pharmacopeia (USP), British Pharmacopoeia (BP), European Pharmacopoeia (EP), and Indian Pharmacopoeia (IP), ensuring standardized quality across different markets.

4India Regulatory Classification

In India, ivermectin is classified as a Schedule H drug under the Drugs and Cosmetics Act, requiring a prescription for dispensing. The National Pharmaceutical Pricing Authority (NPPA) has not set a ceiling price for ivermectin, allowing market-driven pricing. For exports, the Directorate General of Foreign Trade (DGFT) mandates a No Objection Certificate (NOC) to ensure that domestic supply is not adversely affected by export activities.

5Patent & Exclusivity Status

The primary patents for ivermectin have expired, leading to a robust generic market with multiple manufacturers producing the drug. This has resulted in increased competition and more affordable pricing globally.

6Recent Industry Developments

In August 2024, the WHO released guidelines on the public health control of human strongyloidiasis, emphasizing the use of ivermectin as a standard treatment. (who.int) This development is likely to increase global demand for ivermectin.

In September 2025, the WHO updated its Model List of Essential Medicines, reaffirming the inclusion of ivermectin, which may influence procurement policies worldwide. (who.int)

In March 2026, the FDA issued Import Alert 68-19, focusing on unapproved finished new animal drugs, including certain ivermectin products. While this alert primarily targets veterinary applications, it underscores the importance of compliance with FDA regulations for all ivermectin products.

These developments highlight the dynamic regulatory landscape for ivermectin, necessitating continuous monitoring by exporters to ensure compliance and capitalize on emerging opportunities.

TransData Nexus Research · FDA Orange Book, EMA, WHO Model List, CDSCO/NPPAUpdated Mar 2026

Get Complete Export Intelligence Report

300+ pages · Supplier profiles · Buyer analysis · Price benchmarks · Every shipment record

Free

Global Price Benchmark — Ivermectin

Retail & reference prices across 9 markets vs. India FOB export price of $2.31/unit

Global Price Benchmark for Ivermectin across major pharmaceutical markets
Market	Price (USD/unit)	Currency	Reference
United States	$2.50	USD	According to the FDA's Orange Book, Ivermectin is approved for human use in the United States.
United Kingdom	$2.30	GBP	The UK's Medicines and Healthcare products Regulatory Agency (MHRA) lists Ivermectin as a licensed medicine.
Germany	$2.20	EUR	The European Medicines Agency (EMA) has approved Ivermectin for use within the European Union.
Australia	$2.10	AUD

Supply Chain Risk Assessment — Ivermectin

API sourcing, concentration risk, storage requirements, and current alerts

MEDIUM RISK

1API Sourcing & Raw Material Dependency

Ivermectin's production heavily relies on Active Pharmaceutical Ingredients (APIs) and Key Starting Materials (KSMs). India, while a significant producer of APIs, depends on China for approximately 60–70% of its KSMs. This dependency exposes the supply chain to potential disruptions stemming from geopolitical tensions, trade restrictions, or environmental regulations in China. For instance, in recent years, several Chinese API manufacturers faced shutdowns due to non-compliance with pollution norms, leading to supply disruptions and cost escalations.

The COVID-19 pandemic further highlighted these vulnerabilities. During the crisis, China's factory shutdowns led to immediate shortages of essential APIs in India, underscoring the risks of over-reliance on a single country for critical raw materials.

2Supplier Concentration & Single-Source Risk

Our proprietary trade data indicates that the top five Indian exporters of Ivermectin account for 49.7% of the total export value, with SAVA HEALTHCARE LIMITED alone contributing 27.0%. Such concentration poses a significant risk; any operational or compliance issues within these key suppliers could disrupt the entire supply chain.

To mitigate this, the Indian government introduced the Production Linked Incentive (PLI) scheme, aiming to bolster domestic API and KSM production and reduce import dependence. As of November 2024, two greenfield plants were inaugurated under this scheme to manufacture critical molecules like Penicillin G and Clavulanic Acid, marking a step towards self-reliance.

Access Complete Ivermectin Trade Intelligence

Shipment-level records, verified supplier contacts, buyer histories, and pricing analytics for all 11,765 transactions across 140 markets.

Request Demo View Pricing

Frequently Asked Questions — Ivermectin Exports from India

Data-backed answers sourced from Indian Customs shipping bill records

Who are the top ivermectin exporters from India?

The leading ivermectin exporters from India are SAVA HEALTHCARE LIMITED, ZYDUS LIFESCIENCES LIMITED, ANTILA LIFESCIENCES PRIVATE LIMITED, and 12 others. SAVA HEALTHCARE LIMITED leads with 27.0% market share ($2.3M). The top 5 suppliers together control 49.7% of total export value.

What is the total export value of ivermectin from India?

The total export value of ivermectin from India is $8.7M, recorded across 11,765 shipments from 352 active exporters to 140 countries. The average shipment value is $738.

Which countries import ivermectin from India?

India exports ivermectin to 140 countries. The top importing countries are MAURITIUS (30.5%), UNITED STATES (15.4%), MADAGASCAR (10.4%), UNITED ARAB EMIRATES (7.9%), AFGHANISTAN (3.9%), which together account for 68.2% of total export value.

What is the HS code for ivermectin exports from India?

The primary HS code for ivermectin exports from India is 30049099. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) to track and report pharmaceutical export flows.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Ivermectin

Ivermectin

Top Ivermectin Exporters from India

Top Countries Importing Ivermectin from India

Who Supplies Ivermectin to India?

Quick Facts

Related Antimalarial & Antiparasitic

Related Analysis

Need Details?

Regulatory Landscape — Ivermectin

1FDA & US Market Regulatory Status

2EU & UK Regulatory Framework

3WHO Essential Medicines & Global Standards

4India Regulatory Classification

5Patent & Exclusivity Status

6Recent Industry Developments

Global Price Benchmark — Ivermectin

Supply Chain Risk Assessment — Ivermectin

1API Sourcing & Raw Material Dependency

2Supplier Concentration & Single-Source Risk

Access Complete Ivermectin Trade Intelligence

Frequently Asked Questions — Ivermectin Exports from India

Who are the top ivermectin exporters from India?

What is the total export value of ivermectin from India?

Which countries import ivermectin from India?

What is the HS code for ivermectin exports from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

India Cost Advantage

3Geopolitical & Shipping Disruptions

4Risk Mitigation Recommendations

What is the average price of ivermectin exports from India?

Which ports handle ivermectin exports from India?

Why is India a leading exporter of ivermectin?

What certifications do Indian ivermectin exporters need?

How many buyers import ivermectin from India?

What is the market share of the top ivermectin exporter from India?

Analysis Methodology